However, on February 21, 2025, the FDA officially declared that the Ozempic and Wegovy shortage has ended (for now)
Statements Author contributions JP-M: Writing original draft, Writing review & editing, Investigation
Finally, among GLP-1 RA, the Effect of Efpeglenatide on Cardiovascular Outcomes (AMPLITUDE-O) trial demonstrated a beneficial effect of weekly efpeglenatide on MACE and on a composite kidney outcome (decrease in kidney function or severe albuminuria) [247]
Depression and Anxiety: Some preliminary studies have shown that GLP-1 receptor agonists might have antidepressant and anxiolytic effects by influencing brain areas involved in mood regulation
All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners